These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

122 related items for PubMed ID: 5129469

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [The beta-blocking drugs in hyperthyroidism. I. Effects on the cardiovascular syndrome].
    Ghidini O, Bellotti G, De Gregori ME, Salazzari G, Giardina F.
    Minerva Med; 1971 Mar 31; 62(26):1363-73. PubMed ID: 4396565
    [No Abstract] [Full Text] [Related]

  • 3. [Hypothyroidism, hyperthyroidism and therapy with thyroid hormones: effect on the skeletal system].
    Kann P, Jocham A, Beyer J.
    Dtsch Med Wochenschr; 1997 Nov 07; 122(45):1392-7. PubMed ID: 9410717
    [No Abstract] [Full Text] [Related]

  • 4. [Comparative study of the clinical and metabolic effects of triiodothyropropionic acid and of L-triiodothyronine].
    Cattano G, Busonera G, Benedetti A.
    Minerva Med; 1968 Mar 03; 59(18):977-85. PubMed ID: 5646213
    [No Abstract] [Full Text] [Related]

  • 5. [Clinical study of a new beta-blocking agent: LB 46].
    Warembourg H, Ducloux G.
    Lille Med; 1971 Oct 03; 16():Suppl 4:1203-8. PubMed ID: 4399711
    [No Abstract] [Full Text] [Related]

  • 6. [Treatment of patients with hypothyreosis with thyroidin by the method of variable hormonal vacuum].
    Boriak PM.
    Vrach Delo; 1969 Aug 03; 8():27-30. PubMed ID: 5382480
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [The rôle of catecholamines in the clinical manifestations of the hyper- and hypothyroidism syndromes].
    Perrault M, Klotz B, Robillard M.
    Sem Hop; 1968 Jun 20; 44(30):2013-25. PubMed ID: 4300528
    [No Abstract] [Full Text] [Related]

  • 10. [Isoproterenol and cardiovascular reactivity in angina pectoris].
    Starcich R, Barbaresi F, Bacuzzi E, Pavarani A.
    G Clin Med; 1966 Aug 20; 47(8):701-19. PubMed ID: 5989215
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Contribution to the clinical evaluation of beta-adrenergic blocking drugs: 1-p-nitrophenyl-2-isopropylaminoethanol (INPEA) as an antagonist of catecholamines in normal persons and in coronary disease patients.
    Piva M, Ongari R.
    Arzneimittelforschung; 1968 Feb 20; 18(2):179-88. PubMed ID: 5695376
    [No Abstract] [Full Text] [Related]

  • 13. Serum leptin and ghrelin levels in premenopausal women with stable body mass index during treatment of thyroid dysfunction.
    Braclik M, Marcisz C, Giebel S, Orzeł A.
    Thyroid; 2008 May 20; 18(5):545-50. PubMed ID: 18466078
    [Abstract] [Full Text] [Related]

  • 14. [Review of literature and experimental contribution on KO 592, a drug with beta-adrenolytic activity. I].
    Marmo E, Caputi AP, Saini RK.
    Clin Ter; 1972 Jul 15; 62(1):11-51. PubMed ID: 4403671
    [No Abstract] [Full Text] [Related]

  • 15. Administration of triiodothyronine (T3) for the detection of thyroid deficiency in persons on thyroid replacement therapy.
    Hurxthal LM.
    Lahey Clin Found Bull; 1968 Jul 15; 17(3):127-36. PubMed ID: 5743587
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.